Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 12, 2002, Pages 928-946

  Lee, Pyng ^a   Gildea, Thomas R ^a   Stoller, James K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIRETROVIRUS AGENT; BRONCHODILATING AGENT; COCAINE; DAPSONE; DIAMORPHINE; ELASTASE; ELASTASE INHIBITOR; GLUCOCORTICOID; INFLUENZA VACCINE; METHADONE; OXYGEN; PNEUMOCOCCUS VACCINE; TRYPSIN INHIBITOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CUTIS LAXA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; EHLERS DANLOS SYNDROME; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOCOMPLEMENTEMIA; INFLUENZA; INTRAVENOUS DRUG ABUSE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALNUTRITION; MARFAN SYNDROME; METABOLIC DISORDER; PATHOGENESIS; PROTEIN BLOOD LEVEL; REFEEDING; REVIEW; RISK ASSESSMENT; SMOKING; STREPTOCOCCUS INFECTION; THORAX RADIOGRAPHY; URTICARIA; VASCULITIS;

EID: 0036926944     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.12.928     Document Type: Review

References (47)

1. Korn RJ, Dockery DW, Speizer FE, Ware JH, Ferris BG Jr. Occupational exposures and chronic respiratory symptoms: a population-based study. Am Rev Respir Dis 1987; 136:298-304.
2. Becklake MR. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140(suppl):S85-S91.
3. Oxman AD, Muir DC, Shannon HS, Stock SR, Hnizdo E, Lange HJ. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Am Rev Respir Dis 1993; 148:38-48.
4. Snider G, Klinerman J, Thurlbeck WM. The definition of emphysema: report of the National Heart, Lung, and Blood Institute Division of Lung Diseases Workshop. Am Rev Respir Dis 1985; 132:182-185.
5. Thurlbeck WM. Overview of the pathology of pulmonary emphysema in the human. Clin Chest Med 1983; 4:337-350.
6. Thurlbeck WM. Pathology of chronic airflow obstruction. In: Cherniak NS, editor. Chronic obstructive pulmonary disease. Philadelphia: W.B. Saunders, 1991.
7. Reid L. The pathology of emphysema. Chicago: Year Book Medical Publishers, 1967.
8. Thurlbeck WM. Chronic airflow obstruction in lung disease. Major problems in pathology. Philadelphia: W. B. Saunders, 1976.
9. Wewers M. Pathogenesis of emphysema. Assessment of basic science concepts through clinical investigation. Chest 1989; 95:190-195.
10. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132:417-433.
11. Larsson C. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978, 204:345-351.
12. Eriksson S. Alpha 1-antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Historic perspectives. Chest 1989; 95:181-189.
13. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986; 314:736-739.
14. Sveger T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294:1316-1321.
15. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha 1-antitrypsin deficiency. Am J Med 1988; 84:13-31.
16. Crystal RG, et al. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 1989, 95:196-208.
17. O'Brien ML, Buist NR, Murphey WH. Neonatal screening for alpha 1-antitrypsin deficiency, J Pediatr 1978, 92:1006-1010.
18. Spence WC, Morris JE, Pass K, Murphy PD. Molecular confirmation of alpha 1-antitrypsin genotypes in newborn dried blood specimens. Biochem Med Metab Biol 1993; 50:233-240.
19. Silverman EK, Miletich JP, Pierce JA, et al. Alpha 1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 140:961-966.
20. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med 1994, 61:461-467.
21. 1 decline in individuals with severe deficiency of alpha 1-antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59.
22. Brantly ML, et al. Clinical features and history of the destructive lung disease associated with alpha 1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138:327-336.
23. Cuvelier A, Muir JF, Hellot MF, et al. Distribution of alpha 1-antitrypsin alleles in patients with bronchiectasis. Chest 2000; 117:415-419.
24. Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest 1993; 103:812-815.
25. Beighton P. The dominant and recessive forms of cutis laxa. J Med Genet 1972; 9:216-221.
26. Byers PH, Siegel R, Holbrook KA, et al. X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med 1980; 303:61-65.
27. Cupo LN, Pyeritz RE, Olson JL, McPhee SJ, Hutchins GM, McKusick VA. Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema, and cerebral heterotopias. Am J Med 1981; 71:1051-1058.
28. Pare JP, Cote G, Fraser RS. Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis 1989; 139:233-241.
29. Stern EJ, Frank MS, Schmutz JF, Glenny RW, Schmidt RA, Godwin JD. Panlobular pulmonary emphysema caused by IV injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. Am J Roentgenol 1994; 162:555-560.
30. Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992; 116:124-128.
31. Diaz PT, King ER, Wewers MD, et al. HIV infection increases susceptibility to smoking-induced emphysema. Chest 2000; 117(5 suppl 1):285S.
32. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132:369-372.
33. Gurney JW, Bates FT. Pulmonary cystic disease: comparison of pneumocystis carinii pneumatoceles and bullous emphysema due to intravenous drug abuse. Radiology 1989; 173:27-31.
34. Wisnieski JJ, Baer AN, Christensen J, et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore) 1995; 74:24-41.
35. Schwartz HR, McDuffie FC, Black LF, et al. Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc 1982; 57:231-238.
36. Sahebjami H. Emphysema-like changes in HIV [letter]. Ann Intern Med 1992; 116:876.
37. Paakko P, Ryhanen L, Rantala H, Autio-Harmainen H. Pulmonary emphysema in a nonsmoking patient with Salla disease. Am Rev Respir Dis 1987; 135:979-982.
38. Christiano AM, Uitto J. Molecular pathology of the elastic fibers. J Invest Dermatol 1994, 103(5 suppl):53S-57S.
39. Sanders C. The radiographic diagnosis of emphysema. Radiol Clin North Am 1991; 29:1019-1030.
40. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:555-569.
41. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1285-1291.
42. McNicholas WT. Impact of sleep in respiratory failure. Eur Respir J 1997; 10:920-933.
43. McNally E, Fitzpatrick M, Bourke S, et al. Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J 1993; 6:1353-1356.
44. Brantly M. Report of the WHO meeting on alpha 1-antitrypsin defiency. In: Human Genetics Programme Division of Noncommunicable Diseases. Geneva: World Heath Organization, 1996.
45. Abboud RT, Ford GT, Chapman KR. Alpha 1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J 2001; 8:81-88.
46. American Thoracic Society. Guidelines for the approach to the patient with severe hereditary alpha 1-antitrypsin deficiency. Am Rev Respir Dis 1989; 140:1494-1497.
47. Fortson JS. Hypocomplementemic urticarial vasculitis syndrome respponse to dapsone. J Am Acad Dermatol 1986; 15(5 pt 2): 1137-1142.